Log In
Print this Print this

Vitravene, Fomivirsen (ISIS 2922)

  Manage Alerts
Collapse Summary General Information
Company Ionis Pharmaceuticals Inc.
DescriptionAntisense inhibitor of cytomegalovirus (CMV) IE2
Molecular Target CMV DNA
Mechanism of ActionViral replication inhibitor
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentMarketed
Standard IndicationCytomegalovirus (CMV)
Indication DetailsTreat advanced cytomegalovirus (CMV) retinitis in AIDS; Treat cytomegalovirus (CMV) in AIDS patients who have failed current therapies and whose disease is progressing; Treat cytomegalovirus (CMV) retinitis; Treat cytomegalovirus (CMV) retinitis in AIDS patients
Regulatory Designation
PartnerNovartis AG

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today